Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: A meta analysis

European Journal of Cancer

Volumn 49, Issue 4, 2013, Pages 843-851

  An, Xin ^a   Lin, Xi ^a   Wang, Feng Hua ^a   Goodman, Karyn ^b   Cai, Pei Qiang ^a   Kong, Ling Heng ^a   Fang, Yu Jing ^a   Gao, Yuan Hong ^a   Lin, Jun Zhong ^a   Wan, De Sen ^a   Pan, Zhi Zhong ^a   Ding, Pei Rong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemoradiotherapy; Meta analysis; Neoadjuvant; Oxaliplatin

Indexed keywords

CAPECITABINE; FLUOROURACIL; OXALIPLATIN;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; HUMAN; META ANALYSIS; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; RECTUM CANCER; STOMA; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84873712641     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.026     Document Type: Article

References (35)

1. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 11 2006 1114 1123
2. E. Kapiteijn, C.A. Marijnen, and I.D. Nagtegaal Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 9 2001 638 646
3. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 17 2004 1731 1740
4. J.P. Gerard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 28 2006 4620 4625
5. C. Aschele, and S. Lonardi Multidisciplinary treatment of rectal cancer: medical oncology Ann Oncol 18 Suppl. 9 2007 ix114 ix121
6. R.M. Goldberg, D.J. Sargent, and R.F. Morton A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer J Clin Oncol 22 1 2004 23 30
7. T. Andre, C. Boni, and L. Mounedji-Boudiaf Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 23 2004 2343 2351
8. J. Kjellstrom, E. Kjellen, and A. Johnsson In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line Acta Oncol 44 7 2005 687 693
9. E. Francois, M. Ychou, and M. Ducreux Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study Eur J Cancer 41 18 2005 2861 2867
10. C. Aschele, M.L. Friso, and S. Pucciarelli A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer Ann Oncol 16 7 2005 1140 1146
11. D.P. Ryan, D. Niedzwiecki, and D. Hollis Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901 J Clin Oncol 24 16 2006 2557 2562
12. J.P. Gerard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 10 2010 1638 1644
13. C. Aschele, L. Cionini, and S. Lonardi Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial J Clin Oncol 29 20 2011 2773 2780
14. M.S. Roh GAY, M.J. O'Connell, and R.W. Beart The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum J Clin Oncol 29 s 2011 abstr. 3503
15. C. Rodel, T. Liersch, and H. Becker Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 7 2012 679 687
16. M.S. Roh, G.A. Yothers, and M.J. O'Connell The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum J Clin Oncol 29 s 2011 abstr. 3503
17. D.L. Demets Methods for combining randomized clinical trials: strengths and limitations Stat Med 6 3 1987 341 350
18. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188
19. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 11 2002 1539 1558
20. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 557 560
21. D.G. Haller, P.J. Catalano, and J.S. Macdonald Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089 J Clin Oncol 23 34 2005 8671 8678
22. Y. Dencausse, G. Hartung, and J. Sturm Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin Onkologie 25 5 2002 426 430
23. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis group in cancer J Clin Oncol 16 1 1998 301 308 http://www.ncbi.nlm.nih.gov/sites/entrez? otool=mskcclib&dr=abstract&cmd=Search&db=pubmed&term= Efficacy%20of%20intravenous%20continuous%20infusion%20of%20fluorouracil%20compa red%20with%20bolus%20administration%20in%20advanced%20colorectal%20cancer. %20Meta-analysis%20Group%20In%20Cancer
24. M.J. O'Connell, J.A. Martenson, and H.S. Wieand Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 8 1994 502 507
25. L.F. de Campos-Lobato, L. Stocchi, and A. da Luz Moreira Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence Ann Surg Oncol 18 6 2011 1590 1598
26. S.G. Yeo, D.Y. Kim, and T.H. Kim Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01) Ann Surg 252 6 2010 998 1004
27. F. JB Bonnetain, J. Gerard, and G. Calais An analysis of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer on survival in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? J Clin Oncol 29 s 2011 abstr 3506
28. Y.J. Chua, Y. Barbachano, and D. Cunningham Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial Lancet Oncol 11 3 2010 241 248
29. R. Hofheinz, F.K. Wenz, S. Post, A. Matzdorff, S. Laechelt, and J.T. Hartmann Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): long-term results of a randomized, phase III trial J Clin Oncol 29 15s 2011 abstr. 3504
30. B.D. Minsky Counterpoint: long-course chemoradiation is preferable in the neoadjuvant treatment of rectal cancer Semin Radiat Oncol 21 3 2011 228 233
31. M. Maas, P.J. Nelemans, and V. Valentini Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 9 2010 835 844
32. L.A. Stewart, and M.K. Parmar Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 341 8842 1993 418 422
33. V.M. Montori, M.F. Swiontkowski, and D.J. Cook Methodologic issues in systematic reviews and meta-analyses Clin Orthop Relat Res 413 2003 43 54
34. L.A. Stewart, and J.F. Tierney To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data Eval Health Prof 25 1 2002 76 97
35. G.R. Bria E, and H. Raftopoulos Comparing two methods of meta-analysis in clinical research-individual patient data-based (IPD) and literature-based abstracted data (AD) methods: Analyzing five oncology issues involving more than 10,000 patients in randomized clinical trials (RCTs) J Clin Oncol 25 325s 2007 abstr. 6512